Long‐term impact of β‐blocker in elderly patients without myocardial infarction after percutaneous coronary intervention

Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe

(2019) Christina Magnussen et al.   JACC-Heart Failure

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

(2019) Satoshi Umemura et al.   HYPERTENSION RESEARCH

Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients

(2019) Kathleen Dungan et al.   Cardiovascular Diabetology

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

(2018) Hector M. Garcia-Garcia et al.   CIRCULATION

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

(2018) Karen A. Hicks et al.   CIRCULATION

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

(2018) Makoto Kinoshita et al.   Journal of Atherosclerosis and Thrombosis

Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials

(2017) Alexandra J Lansky et al.   EUROPEAN HEART JOURNAL

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention

(2016) Apurva A. Motivala et al.   JACC-Cardiovascular Interventions

Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction

(2015) Jeffrey J. Goldberger et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

 -Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction: Post Hoc Analysis From the CHARISMA Trial

(2014) S. Bangalore et al.  

Incidence of and Risk Factors for Sick Sinus Syndrome in the General Population

(2014) Paul N. Jensen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Beta-Blocker Therapy and Cardiac Events Among Patients With Newly Diagnosed Coronary Heart Disease

(2014) Charlotte Andersson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart Rate Response to a Timed Walk and Cardiovascular Outcomes in Older Adults: The Cardiovascular Health Study

(2012) Saket Girotra et al.   CARDIOLOGY

β-blocker use in patients after percutaneous coronary interventions: One size fits all? Worse outcomes in patients without myocardial infarction or heart failure

(2012) Neiko Ozasa et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease

(2012) Sripal Bangalore et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Heart Failure and Chronic Obstructive Pulmonary Disease

(2011) Nathaniel M. Hawkins et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2011 Compendium of Physical Activities

(2011) BARBARA E. AINSWORTH et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

(2009)   DIABETES CARE